MDYG vs. BOUT
MDYG (SPDR S&P 400 Mid Cap Growth ETF) and BOUT (Innovator IBD Breakout Opportunities ETF) are both Mid Cap Growth Equities funds - MDYG tracks the S&P MidCap 400 Growth Index while BOUT tracks the IBD Breakout Stocks Total Return Index. Both are passively managed. Over the past 5 years, MDYG returned 8.66%/yr vs 8.21%/yr for BOUT. A 0.77 correlation means they provide meaningful diversification when combined. MDYG charges 0.15%/yr vs 0.80%/yr for BOUT.
Performance
MDYG vs. BOUT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDYG achieves a 19.44% return, which is significantly lower than BOUT's 31.14% return.
MDYG
- 1D
- 0.27%
- 1M
- 4.57%
- YTD
- 19.44%
- 6M
- 18.73%
- 1Y
- 30.20%
- 3Y*
- 18.49%
- 5Y*
- 8.66%
- 10Y*
- 11.58%
BOUT
- 1D
- -0.19%
- 1M
- 2.96%
- YTD
- 31.14%
- 6M
- 29.42%
- 1Y
- 34.29%
- 3Y*
- 17.47%
- 5Y*
- 8.21%
- 10Y*
- —
MDYG vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
MDYG SPDR S&P 400 Mid Cap Growth ETF | 19.44% | 7.22% | 15.84% | 17.30% | -18.92% | 18.46% | 22.57% | 26.10% | -18.85% |
BOUT Innovator IBD Breakout Opportunities ETF | 31.14% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 50.56% | 20.59% | -29.80% |
Correlation
The correlation between MDYG and BOUT is 0.79, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.79 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Sep 14, 2018 | 0.77 |
The correlation between MDYG and BOUT has been stable across timeframes, ranging from 0.77 to 0.82 - a consistent structural relationship.
MDYG vs. BOUT - Sectors Allocation Comparison
Sectors
MDYG
BOUT
Industrials
Technology
Healthcare
Consumer Cyclical
Financial Services
Real Estate
Energy
Basic Materials
Consumer Defensive
Utilities
Communication Services
Industrials
MDYG
BOUT
Technology
MDYG
BOUT
Healthcare
MDYG
BOUT
Consumer Cyclical
MDYG
BOUT
Financial Services
MDYG
BOUT
Real Estate
MDYG
BOUT
Energy
MDYG
BOUT
Basic Materials
MDYG
BOUT
Consumer Defensive
MDYG
BOUT
Utilities
MDYG
BOUT
Communication Services
MDYG
BOUT
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDYG vs. BOUT — Risk / Return Rank
MDYG
BOUT
MDYG vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P 400 Mid Cap Growth ETF (MDYG) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MDYG | BOUT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | +0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.29 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.06 | 2.93 | +0.13 |
| Martin ratioReturn relative to average drawdown | 12.24 | 8.75 | +3.49 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MDYG | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.78 | 1.66 | +0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.42 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.41 | +0.07 |
Drawdowns
MDYG vs. BOUT - Drawdown Comparison
The maximum MDYG drawdown since its inception was -58.44%, which is greater than BOUT's maximum drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for MDYG and BOUT.
Loading charts...
Drawdown Indicators
| MDYG | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.44% | -36.75% | -21.69% |
Max Drawdown (1Y)Largest decline over 1 year | -9.91% | -11.76% | +1.85% |
Max Drawdown (3Y)Largest decline over 3 years | -25.45% | -25.31% | -0.14% |
Max Drawdown (5Y)Largest decline over 5 years | -29.26% | -28.28% | -0.98% |
Max Drawdown (10Y)Largest decline over 10 years | -39.27% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.19% | +0.19% |
Average DrawdownAverage peak-to-trough decline | -8.03% | -12.29% | +4.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.47% | 3.93% | -1.46% |
Volatility
MDYG vs. BOUT - Volatility Comparison
The current volatility for SPDR S&P 400 Mid Cap Growth ETF (MDYG) is 5.08%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 5.46%. This indicates that MDYG experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDYG | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.08% | 5.46% | -0.38% |
Volatility (6M)Calculated over the trailing 6-month period | 13.21% | 16.00% | -2.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.01% | 20.78% | -3.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.62% | 19.48% | +1.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.05% | 22.93% | -1.88% |
MDYG vs. BOUT - Expense Ratio Comparison
MDYG has a 0.15% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Dividends
MDYG vs. BOUT - Dividend Comparison
MDYG's dividend yield for the trailing twelve months is around 0.61%, more than BOUT's 0.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% | 0.00% | 0.00% |
MDYG SPDR S&P 400 Mid Cap Growth ETF | 0.61% | 0.75% | 0.87% | 1.20% | 1.16% | 0.69% | 0.71% | 1.21% | 1.36% | 2.23% | 1.25% | 2.51% |
Frequently Asked Questions
MDYG and BOUT have a correlation of 0.79, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BOUT has higher volatility (5.46%) compared to MDYG (5.08%). In terms of maximum drawdown, MDYG dropped -58.44% vs BOUT's -36.75%.
On 5-year performance, MDYG leads with 8.66% vs 8.21% for BOUT. On fees, MDYG is cheaper at 0.15% per year. On volatility, MDYG has been the lower-risk option at 5.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, MDYG has performed better with a 8.66% return vs 8.21%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
MDYG is cheaper with a 0.15% expense ratio, compared with 0.80% for BOUT.
MDYG has the higher dividend yield at 0.61%, compared with 0.26% for BOUT.
MDYG tracks S&P MidCap 400 Growth Index, while BOUT tracks IBD Breakout Stocks Total Return Index. They also come from different issuers: State Street and Innovator. Their fees differ too: 0.15% for MDYG and 0.80% for BOUT.
MDYG currently has the higher Sharpe Ratio (1.78 vs 1.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDYG and BOUT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer